Placeholder

Experts: Thought Leaders

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

Product Description

Mike Ackermann, Ph.D. Senior VP, Global Commercial Solutions, Quintiles, a ­biopharmaceutical services company offering fully integrated clinical, commercial, consulting, and capital solutions. For more information, visit quintiles.com.

Faraz Ali. VP, Program Management and Commercial Planning, bluebird bio, which is developing innovative gene therapies for ­severe genetic disorders. For more information, visit bluebirdbio.com.

Jodi Amendola. CEO, Amendola ­Communications, a healthcare and healthcare IT-focused, public relations and marketing firm. For more information, visit acmarketingpr.com.

Miguel Barbosa, Ph.D. VP, Head, ­Immunology Research and External ­Innovation, Janssen Research & Development LLC, part of the Janssen Pharmaceutical ­Companies of Johnson & Johnson, which is ­dedicated to addressing and solving the most important unmet medical needs, including ­oncology, immunology, and nephrology. For more information, visit janssen.com, or follow on Twitter @JanssenUS.

Wendel Barr. CEO, Synteract, a full-service contract research organization that supports biotechnology, medical device, and ­pharmaceutical companies in all phases of clinical development. For more information, visit synteract.com.

Rob Bazemore. President, Janssen Biotech Inc., the biotechnology company of the Janssen Pharmaceutical Companies, which is dedicated to addressing and solving the most important unmet medical needs, including ­oncology, immunology, and nephrology. For more information, visit janssenbiotech.com, or follow on Twitter @JanssenUS.

Joe Bedford. Director of Marketing, Almac, which provides a broad range of services from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and IXRS technology (IVRS/IWRS), to commercial-scale ­manufacturing. For more information, visit ­almacgroup.com.

Chris Bergstrom. Chief Strategy and Commercial Officer, WellDoc, which is ­developing the next generation of technology solutions to support the management of chronic disease. For more information, visit welldoc.com.

Stewart Bieler. Chief Operating Officer, Synteract, is a clinical research organization that is dedicated to providing clinical trial ­solutions. For more information, visit ­synteract.com.

John Blakeley. Chief Commercial Officer, Greenphire, a provider of Web-based clinical payment technology platforms for use by ­research sites, research universities, sponsors, and CROs. For more information, visit
greenphire.com or email
john.blakeley@greenphire.com.

Kathy Bloomgarden. CEO, Ruder Finn, an independent communications agency with a 65-year legacy. For more information, visit ­ruderfinn.com.

Christopher Blotto. Managing Partner, Knowledgent, an information consultancy that combines advanced information ­management and analysis capabilities with deep industry domain expertise to maximize the value of information to empower clients with actionable business insights. For more ­information, visit knowledgent.com.

Jay Bolling. CEO, Roska Healthcare ­Advertising, which executes professional and consumer advertising for a broad base of healthcare clients. For more information, visit roskahealthcare.com or email
jbolling@roskahealthcare.com.
Marc Bonnefoi, D.V.M, Ph.D. Head of the North America R&D Hub and VP of ­Disposition, Safety and Animal Research, Sanofi, a diversified healthcare leader focused on patients’ needs. For more information, visit sanofi.com.

Matt Brown. General Manager, ICC Lowe,  one of the  nine wholly owned ICC Lowe ­offices in the United States and Europe along with a wider network of affiliated European agencies. For more information, visit
trio.icclowe.com.

Stephanie Brown. Interactive Strategy, FingerPaint Marketing, an advertising and marketing agency. For more information, visit fingerpaintmarketing.com.

Adam Budish. Senior VP, Sales, Epocrates, a physician platform for clinical content, practice tools and health industry engagement. For more information, visit epocrates.com.

Richard Butler. Managing Consultant, ­Alliance Life Sciences Consulting Group Inc., a management and technology consultancy. For more information, visit alscg.com.

Erin Byrne. Chief Engagement Officer, ghg,  a global healthcare communications company. For more information, visit ghgroup.com.

Faruk Capan. CEO and Founder, Intouch Solutions, a full-service pharmaceutical ­marketing agency. For more information, visit intouchsol.com.
Jay Carter. Senior VP, Director of Strategy Services, AbelsonTaylor, an independent healthcare agency. For more information,
visit abelsontaylor.com, email
jay.carter@abelsontaylor.com, or follow on
Twitter @AbelsonTaylor or @JayCarterRxAds.

Rodeina Challand. Executive Director, Biosimilars Development, PRA, a CRO
­serving clients across all phases of drug ­development. For more information,
visit prainternational.com.

Robert Chioini. Founder, Chairman, CEO, and President, Rockwell Medical Inc., an ­integrated biopharmaceutical company ­targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD). For more ­information, visit rockwellmed.com.

Ryan Cohlhepp. Senior Director, U.S. ­Marketing, Millennium: The Takeda ­Oncology Company, whose mission is to ­deliver extraordinary medicines to patients with cancer worldwide through its science, ­innovation, and passion. For more information, visit millennium.com.

N. Anthony Coles, M.D. President and CEO, Onyx Pharmaceuticals, a global ­biopharmaceutical company engaged in the development and commercialization of ­innovative therapies for improving the lives of people with cancer. For more information,
visit onyx.com.

Nick Colucci. President and CEO of ­Publicis Healthcare Communications Group, a vertical network that integrates services across its global offices and brands to deliver on clients’ needs. For more information, visit publicishealthcare.com.

Pat Connelly. Head, Public Relations, ­Millennium: The Takeda Oncology ­Company, whose mission is to deliver ­extraordinary medicines to patients with ­cancer worldwide through its science, ­innovation, and passion. For more information, visit millennium.com.

Scott Connor. VP, Marketing, Acurian, a full-service provider of global patient ­enrollment and retention solutions. For more information, visit acurian.com.

Laurie Cooke. CEO, Healthcare ­Businesswomen’s Association, a nonprofit ­organization dedicated to furthering the ­advancement and impact of women in healthcare worldwide. For more information, visit hbanet.org or email lcooke@hbanet.org.

Bill Cooney. President and CEO, MedPoint Digital, which provides diversified technology services for bio/pharmaceutical companies. For more information, visit medpt.com.

Jade Cusick. President, U.S. Marketing ­Insights, Kantar Health, a global, evidence-based decision support partner to the world’s leading pharmaceutical, biotech, device and diagnostic companies. For more information, visit kantarhealth.com, or email jade.cusick@kantarhealth.com, or follow on Twitter @Kantar_Health.

Hugh Davis, Ph.D. VP and Head of ­Biologics Clinical Pharmacology ­Biotechnology Center of Excellence,
Janssen Research &?Development LLC,
part of the Janssen Pharmaceutical ­Companies of ­Johnson & Johnson, which is dedicated to ­addressing and solving
the most important unmet medical needs, ­including oncology, ­immunology, and nephrology. For more ­information, visit janssenrnd.com.
Tim Davis. CEO, Exco InTouch, a provider of mobile and digital patient engagement ­solutions to support clinical, late-phase, and mhealth programs. For more information, visit excointouch.com.

Jim Dayton. Digital Strategy Lead, Intouch Solutions Inc., a digital marketing agency servicing the pharmaceutical industry. For more information, visit intouchsol.com.

Neil de Crescenzo. Senior VP and General Manager, Oracle Health Sciences, which ­delivers a comprehensive, end-to-end suite of software applications for clinical development and healthcare. For more information,
visit oracle.com/healthsciences.

Glen de Vries. President, Medidata ­Solutions, a provider of cloud-based clinical development solutions that enhance the ­efficiency of customers’ clinical trials. For more information, visit mdsol.com, email
gdevries@mdsol.com, or follow on Twitter @CaptainClinical.

Fran DeGrazio. VP, Global Research and Development, West Pharmaceutical Services,  which helps improve the safe delivery of pharma, healthcare, and personal care ­products. For more information,
visit westpharma.com.

Evan Demestihas, M.D. CEO, The Medical Affairs Company, which provides the ­biopharmaceutical, medical device, and ­diagnostics industries with outsourced field-based medical and medical communications services. For more information, visit tmac.com or email edemestihas@tmacmail.com.

Mike Dennelly. Managing Director, evoke interaction, a full-service marketing agency ­focused on building and growing brands within the pharmaceutical and healthcare ­industry. For more information, visit
evokeinteraction.com or email
mike.dennelly@evokeinteraction.com.

Punit Dhillon. Co-Founder, Director, ­President, and CEO, OncoSec Medical, a biotech company developing treatments for advanced-stage skin cancer. For more ­information, visit oncosec.com.

Keith Dionne, Ph.D. President and CEO, Constellation Pharmaceuticals, a ­biopharmaceutical company in the field of ­epigenetics. For more information,
visit constellationpharma.com.

Darlene Dobry. President, Ogilvy ­CommonHealth Medical Marketing, part of Ogilvy CommonHealth Worldwide, which ­represents an assembly of creative talent in healthcare communications around the world. For more information, visit ogilvychww.com.

Eve Dryer. Founder, Eve Dryer Healthcare Consulting, a healthcare stakeholder ­engagement and patient advocacy company. For more information, email
edryer@voxmedica.com.

Dave Espenshade. Senior VP, Sales and Marketing, Y-Prime Technologies LLC, which leverages platform technology and systems intelligence to provide novel, personalized ­decision-making solutions to life-sciences companies. For more information,
visit y-prime.com.

Oliver Fetzer, Ph.D. CEO, Cerulean Pharma Inc., a platform-based, product-
driven company that develops dynamically tumor-targeted nanopharmaceuticals. For more information, visit ceruleanrx.com.

Patrick Flochel. Global Pharmaceutical Leader, Ernst & Young, a professional services organization that helps companies across the globe to identify and capitalize on business opportunities. For more information, visit ey.com.

Todd Forte. Executive VP, MCS Healthcare Public Relations, an independent, global communications agency. For more ­information, visit mcspr.com.

Chris Garabedian. CEO, Sarepta ­Therapeutics, a developer of first-in-class RNA-based therapies to improve and save the lives of people affected by life-threatening ­diseases. For more information,
visit sareptatherapeutics.com.

Matt Giegerich. Chairman and CEO, Ogilvy CommonHealth Worldwide, part of the Ogilvy & Mather network and a WPP ­company, which represents an assembly of creative talent in healthcare communications around the world. For more information, visit ogilvychww.com.

Glen Giovannetti. Global Life Sciences Leader, Ernst & Young, a professional services organization that helps companies across the globe to identify and capitalize on business opportunities. For more information, visit ey.com.

Claire Gillis. CEO, WG Consulting, which provides market access consultancy services for all healthcare stakeholders, including the pharmaceutical, medical devices, and ­diagnostics industries; the independent ­sector; European state healthcare providers; and academia. For more information, visit ­wg-group.com.

Dan Glass. VP, eContent Management,
Y-Prime, which leverages platform technology and systems intelligence to provide ­personalized decision-making solutions to
life-sciences companies. For more information, visit y-prime.com.

Richard Grant. Director, Life Science and Pharmaceutical, Invetch, which delivers ­product design and development, contract manufacturing, and custom automation ­services to a range of global market sectors, including diagnostics, life sciences, medical
devices, cleantech, industrial, and consumer products. For more information, visit
invetech.com.au or follow on Twitter
@Invetech.

Kerry Greenwood. VP, Global Sales, ­ClearPoint, which provides learning solutions from product launch to mLearning ­frameworks. For more information,
visit ­clearpointlearning.com.

Brian Griner, Ph.D. Chief Methodologist, Market Intelligence, Consulting, Quintiles, biopharmaceutical services company offering fully integrated clinical, commercial, ­consulting, and capital solutions. For more ­information, visit quintiles.com.

Frances Grote. Senior Director, Clinical Outsourcing, Millennium: The Takeda ­Oncology Company, whose mission is to ­deliver extraordinary medicines to patients with cancer worldwide through its science, ­innovation, and passion. For more information, visit millennium.com.

Mark Grove. Senior VP, Business ­Development, Qforma, a healthcare data ­analytics company and a provider of ­predictive modeling and physician social ­networking technologies for health sciences companies. For more information, visit qforma.com, or email mgrove@qforma.com.

Matt Hahn, Ph.D. Senior VP and Chief Technology Officer, Accelrys, a scientific ­enterprise R&D software and services ­company. For more information, visit accelrys.com.

Mike Haley. VP, Life Sciences, Genpact, a global provider of business process ­management and technology services. For more information, visit genpact.com.

Melissa Hammond. Managing Director, Snowfish LLC, a management consulting firm that helps executives in the pharmaceutical, medical device, and biotechnology industries. For more information, visit snowfish.net.

John Haney. VP, Immunology, Marketing, the biotechnology compnay of the Janssen ­Pharmaceutical Companies, which is ­dedicated to addressing and solving the most important unmet medical needs, including oncology, immunology, and nephrology. For more information, visit janssen.com, or follow on Twitter @JanssenUS.

Michael Hanna Jr., Ph.D. President and CEO, Vaccinogen, a biotechnology company with more than three decades of research into combating cancer by using the body’s own immune system. For more information, visit vaccinogen.com.

Bob Harrell. VP Marketing, Healthcare, Appature, a provider of cloud-based ­marketing solutions designed exclusively for healthcare companies. For more information, visit appature.com.

Kent Harris. Senior VP, Business ­Development, West Coast, Qforma, a
healthcare data analytics company and a provider of predictive modeling and physician social networking technologies for health ­sciences companies. For more information, visit qforma.com.

Rob Hayes, Ph.D. VP and Venture Leader, Centyrex Venture, Biotechnology Center of Excellence, at Janssen Research & ­Development LLC, part of the Janssen ­Pharmaceutical Companies of Johnson & ­Johnson, which is dedicated to addressing and solving the most important unmet medical needs, in oncology, immunology, neuroscience, infectious disease, and cardiovascular, and metabolic diseases. For more information, visit janssenrnd.com.

Colin Hill. CEO, President, Chairman, and Co-Founder, GNS Healthcare, a healthcare ­analytics company. For more information, visit gnshealthcare.com.

Arthur Hiller. CEO, SciFluor Life Sciences, a leader in fluorine expertise and innovative fluorine technology. For more information, visit scifluor.com.

Kerry Hilton. CEO, HCB Health, a
full-service advertising agency, built from the ground up to meet the evolving needs of modern healthcare brands. For more ­information, visit hcbhealth.com.

Steve Hoffman. Chief Pharmacy Officer, McKesson Patient Relationship Solutions, a division of McKesson Corporation, focused on offering innovative adherence programs that help pharmaceutical manufacturers stay ­engaged with their patients while providing patients the support they need. For more ­information, visit mckesson.com.

Becky Holloway. Product Marketing ­Manager, Revitas, which delivers integrated solutions for contracts, pricing, and compliance that drive higher profitability and lower risk. For more information, visit revitas.com.

Mark Hronec. Director, Pharmaceutical R&D Advisory Service, PwC, a network of firms in 158 countries committed to delivering quality in assurance, tax, and advisory services. For more information, visit pwc.com.

John Hudak. President and Founder, ­Criterium, a contract research organization ­addressing every phase of development from preclinical to Phase IV. For more information, visit criteriuminc.com.

Yuichi Iwaki, M.D., Ph.D. President, CEO, and Founder of MediciNova Inc., a ­biopharmaceutical company founded upon acquiring and developing novel, small-
molecule therapeutics. For more information, visit medicinova.com or email
info@medicinova.com.

Anand Iyer, Ph.D. President and Chief ­Operating Officer, WellDoc, a ­developer of the next generation of technology solutions to support chronic disease management. For more information, visit welldoc.com.

Graeme Jacombs. Managing Director – Asia-Pacific, Middle East and Africa, Kantar Health, a global, evidence-based decision ­support partner. For more information,
visit katorhealth.com, email
graeme.jacombs@kantarhealth.com or follow on Twitter @Kantar_Health.

Tom Jones. Senior VP, Health Practice, Makovsky, a global integrated ­communications firm. For more information, visit makovsky.com or tjones@makovsky.com.

Balkrishan Kalra. Senior VP, Life ­Sciences, Retail, Consumer Goods, Genpact, which provides business process consulting, technology services, business process services. For more information, visit genpact.com.

Liz Kay. VP, Business Development, ­Healthcare, Cramer, a creative marketing agency focused on engaging audiences both face-to-face and online. For more information, visit cramer.com.

Rick Keefer. President and CEO of Publicis Touchpoint Solutions Inc., which designs and implements healthcare sales, service, and ­communications teams to deliver customized cross-channel solutions. For more information, visit touchpointsolutions.com.

Gillian King. Head of Global Consulting, Global Professional Services, CSC Life ­Sciences, which provides technology-enabled business solutions and services. For more ­information, visit csc.com.

Michael Kirchengast, Ph.D. VP, Scientific Affairs, PRA, a contract research organization serving clients across all phases of drug ­development. For more ­information, visit
prainternational.com.

Shiv Krishnan, Ph.D. Senior Director, Scouting and Partnering, US, Sanofi R&D, a diversified healthcare company focused on ­patients’ needs. For more information, visit sanofi.com.
Michael Kuss. VP of Analgesia, Premier ­Research, a global CRO serving biotech, ­pharmaceutical, and medical device ­corporations. For more information, visit ­premier-research.com.

Donna LaVoie. President and CEO, LaVoie Group, a provider of strategy consulting and integrated communications programs ­designed to properly position and drive ­engagement, create visibility, and value. For more information, visit lavoiegroup.com.

Andy Lee. Deputy Head of Clinical Sciences and Operations, Sanofi, a diversified ­healthcare company focused on patients’ needs. For more information, visit sanofi.com.

Andrea Levin. Associate Director, Public Relations and Communications, UCB, a ­biopharmaceutical company focused on ­severe diseases. For more information, visit ucb.com, or email andrea.levin@ucb.com.

Ilyssa Levins. President, Center for ­Communication Compliance (CCC), a source for training, testing, and consulting in ­promotional regulatory compliance and risk communication. For information, visit ­communicationcompliance.com or email ilevins@communicationcompliance.com.

Andy Levitt. Founding Partner, HealthTalker, which develops word-of-mouth marketing programs for the pharmaceutical and biotechnology industries. For more ­information, visit healthtalker.com, or email andy@healthtalker.com, or follow on ­Twitter @andylevitt.

Henry Levy. Managing Director of Research and Development, Life Sciences Practices, Accenture, a global management consulting, technology services, and outsourcing ­company helping clients become high-
performance businesses. For more information, visit accenturelifesciences.com, or email henry.d.levy@accenture.com.

Jonathan Lewis, M.D., Ph.D. CEO, ­Ziopharm Oncology, a biopharmaceutical company focused on the discovery and ­development of new cancer therapies. For more information, visit ziopharm.com.

Jay Licther, Ph.D. Managing Partner, Avalon Ventures, an early-stage venture ­capital fund focused on information ­technology and life sciences. For more ­information, visit avalon-ventures.com.

Brian Loew. Co-Founder and CEO, Inspire, which builds online communities for patients and caregivers and helps life-sciences ­organizations connect with them. For more ­information, visit corp.inspire.com.

Miguel Louzan. VP and Head of ­Information Technology, UCB Inc., a ­biopharmaceutical company focused on ­severe diseases. For more information,
visit ucb.com

Nancy Lurker. CEO, PDI Inc., a healthcare commercialization company providing ­integrated multichannel message delivery. For more information, visit pdi-inc.com or email ­officeoftheceo@pdi-inc.com.

Alistair Macdonald. President, Clinical Development Services, INC Research, a ­therapeutically focused CRO. For more ­information, visit incresearch.com or follow on Twitter @inc_research.

Jaime Macdonald. Chief Operating ­Officer, INC Research, a therapeutically ­focused CRO. For more information, visit ­incresearch.com or follow on
Twitter @inc_research.

Chris Mahoney. Directory Healthcare Strategy, Cynergy, which leverages a single, ­integrated team of strategists, designers, and technologists to deliver digital experiences. For more information, visit cynergy.com.

Julie Manganella. Senior VP, Marketing and Creative Services, Catalina Health, a healthcare company that uses transactional level insight to help partners develop ­customized, measurable, treatment-related messages that can incite healthier patient ­outcomes. For more information, visit ­catalinamarketing.com.

Abby Mansfield. Senior VP/Creative
Director, Topin & Associates, a full-service ­independent healthcare advertising agency. For more information, visit topin.com or email amansfield@topin.com.

Michelle Marlborough. Director, ­Product Management, Medidata Solutions Solutions, a provider of cloud-based clinical development solutions that enhance the ­efficiency of customers’ clinical trials. For more information, visit mdsol.com.

Mark McConaghy. Senior Director, ­Strategy, evoke interaction, a full-service healthcare agency focused on building and growing brands within the pharmaceutical and healthcare industry. For more information, visit evokeinteraction.com.

Philip McCrea. CEO, ClearPoint, which ­provides learning solutions from product launch to mLearning frameworks. For more ­information, visit clearpointlearning.com.

Andrea McGonigle. Managing Director, Life Sciences, Microsoft, a provider of ­software, services, and solutions to help people and businesses realize their full potential. For more information, visit microsoft.com.

Ryan McGuire. Research Team Leader, ­Cutting Edge Information, a provider of ­management analysis reports, customized ­research, and consulting to pharmaceutical, biotech, and other life-sciences companies. For more information, visit cuttingedgeinfo.com.

Greg Moody. Director, Clinical Informatics, Millennium: The Takeda Oncology Company, whose mission is to deliver extraordinary ­medicines to patients with cancer worldwide through its science, innovation, and passion. For more information, visit millennium.com.

Rick Morrison. Founder and CEO, ­Comprehend Systems, which offers clinical data visualization, analytics, and reporting ­software to improve the way clinical ­researchers access, understand, explore, and analyze data. For more information, visit comprehend.com, email rmorrison@comprehend.com, or follow on Twitter @morrisor.

Jim Murphy. President, Almac Clinical ­Technologies, which provides a broad range of services from R&D, biomarker discovery, and development, API manufacture, formulation development, clinical trial supply and IXRS technology (IVRS/IWRS), to commercial-scale manufacturing. For more information, visit ­almacgroup.com.

Keith Murphy. CEO, Organovo Inc., a three-dimensional biology company focused on ­delivering bioprinting technology and creating tissue on demand for research and medical ­applications. For more information, visit organovo.com or follow on Twitter @Organovo.

Marian Nakada, Ph.D. VP, Strategy and Operations and External Innovation, Biotechnology Center of Excellence, Janssen Research & Development LLC, part of the Janssen Pharmaceutical Companies of ­Johnson & Johnson, which is dedicated to ­addressing and solving the most important unmet medical needs, including oncology, ­immunology, neuroscience, infectious
disease, and cardiovascular, and metabolic ­diseases. For more information,
visit janssenrnd.com.

Trish Nettleship. Director, Social Media and Influence, UCB, a biopharmaceutical ­company focused on severe diseases. For more information, visit ucb-usa.com, or email trish.nettleship@ucb.com.

Terence Nugent. Executive VP Sales and Marketing, Medical Marketing Service Inc. (MMS), a provider of email marketing, lists, and databases for healthcare professional ­marketing. For more information, visit ­mmslists.com, email t-nugent@mmslists.com, or follow on Twitter @mmsemail.

Martin O’Brien. Partner, Healthcare ­Strategy and Planning, Rosetta, an interactive marketing agency. For more information,
visit rosetta.com.

Daniel O’Connor. CEO, InnovoCommerce, which provides Microsoft SharePoint-based clinical and investigator portal solutions. For more information, visit innovocommerce.com or email info@innovocommerce.com.

Lynn O’Connor Vos. CEO, ghg, a global healthcare communications company. For more information, visit ghgroup.com.

Michael O’Gorman. CEO, Sentrx, a provider of pharmacovigilance outsourcing services and technology-enabled solutions and services for global drug safety. For more information, visit sentrx.com.

David Ormesher. CEO, closerlook inc., which offers a full breadth of strategic, ­technology, creative, and account services. For more information, visit closerlook.com, email dormesher@closerlook.com or follow on
Twitter @ormshr.

Joshua Pagliaro. Director, Management Consulting, PwC, a network of firms in 158 countries committed to delivering quality in assurance, tax, and advisory services. For more information, visit pwc.com., or email joshua.pagliaro@us.pwc.com.

Manisha Pai. Director, Corporate ­Communications, Millennium: The Takeda Oncology Company, whose mission is to ­deliver extraordinary medicines to patients with cancer worldwide through its science, ­innovation, and passion. For more information, visit millennium.com.

Gabrielle Pastore. VP, Global Strategic Commercial Innovation, Cadient Group, a digital healthcare marketing agency serving a range of industries, including pharma, biotech, medical devices, hospital/healthcare systems, institutions, and associations. For more ­information, visit cadient.com, or email gabrielle.pastore@cadient.com.

Devin Paullin. Executive VP, Physicians ­Interactive, a division of Skyscape.com Inc., a resource for healthcare information, ­medication samples, and mobile decision ­support tools to medical professionals. For more information, visit physiciansinteractive.com.

Sanjay Pingle. President, Physicians ­Interactive, a division of Skyscape.com Inc., a resource for healthcare information, ­medication samples, and mobile decision ­support tools to medical professionals. For more information, visit physiciansinteractive.com.

bet price. Executive VP, The Medical Affairs Company, which provides the ­biopharmaceutical, medical device, and ­diagnostics industries with outsourced
field-based medical and medical ­communications services. For more ­information, visit tmac.com or email
edemestihas@tmacmail.com.

Mohan Purushothaman, Ph.D. ­Executive VP, Alliance Life Sciences ­Consulting Group, a management and ­technology consultancy. For more information, visit alscg.com.

Andy Pyfer. Marketing Strategy, ­FingerPaint Marketing, an advertising and marketing agency. For more information, visit fingerpaintmarketing.com.

Derek Rago. VP, Strategy and Marketing, McKesson Patient Relationship Solutions, a division of McKesson Corporation, offers ­adherence programs that help manufacturers stay engaged with their patients while ­providing patients the support they need.
For more information, visit mckesson.com/MPRS, or email derek.rago@mckesson.com.

Rick Randall. Founder and Chief Patient Success Officer, Triplefin LLC, which provides pharmaceutical marketing support solutions, including patient reimbursement support services, patient assistance programs, ­traditional and alternative Rx sampling, and ­patient adherence solutions. For more ­information, visit triplefin.com.

William Reese. Chief Innovation Officer, ­Cadient Group, a digital healthcare marketing agency serving a range of industries, including pharma, biotech, medical devices, hospital/ healthcare systems, institutions, and associations. For more information, visit ­cadient.com or email william.reese@cadient.com.

Ken Ribotsky. President and CEO, ­Brandkarma, which offers healthcare ­companies strategic and creative marketing for specialty pharmaceutical, biotech, medical ­device, diagnostics, and OTC brands. For more information, visit brandkarma.org, email at ken.r@brandkarma.org, or follow on Twitter @KenRibotsky.

Greg Rice. Senior VP, Strategy, Klick Health, an independent digital health agency ­developing experiences rooted in strategic and marketing insights, creative thinking, and technological expertise. For more information, visit klick.com.

Sheila Rocchio. VP, Marketing and Product Management, PHT Corp., a provider of ­patient-driven e-data systems used to collect PRO and eCOA in clinical trials around the world. For more information, visit phtcorp.com or email srocchio@phtcorp.com.

Charlene Sanders. VP, Regulatory Affairs and Pediatric Consulting, Premier Research, a full-service, international CRO supporting ­oncology, neuroscience, analgesia, ­cardiovascular, pediatric, and medical device clinical trials. For more information, visit ­premier-research.com.

Ron Scalici. Chief Innovations Officer, Group DCA, a PDI company, which offers ­integrated, multichannel personal and
nonpersonal promotion. For more ­information, visit pdi-inc.com/digital_strategy or email ron.scalici@groupdca.com.

Barry Schmader. Executive VP, Chief ­Creative Officer, Dudnyk, an independently owned, full-service branding, medical ­marketing, and advertising agency. For more information, visit dudnyk.com or email bschmader@dudnyk.com.

Laurent Schockmel. President, Latin America and Chief Strategy Officer, Cegedim Relationship Management, a provider of ­customer relationship ­management solutions. For more information, visit cegedim.com or email ­laurent.schockmel@cegedim.com.

Dieter Seitz-Tutter, Ph.D. VP, Global ­Clinical Development, Europe, Chiltern, a full-service, global contract research organization with experience in the management of Phase I-IV clinical trials. For more information,
visit chiltern.com, or email
dieter.seitz-tutter@chiltern.com.

Greg Seminack. President, CFS Clinical, a specialty provider focused on the business and financial management activities for clinical ­trials. For more information, visit cfsclinical.com.

Lou Shapiro. Senior VP, Business ­Development, Tunstall AMAC, a global provider of 24/7 healthcare communication services to connect individuals, caregivers, and healthcare providers to empower better health. For more information, visit ­tunstallamac.com.

Paul Shawah. CRM Strategy, Veeva ­Systems, a provider of cloud-based
business solutions for the global life-sciences industry. For more information, visit
veevasystems.com.

Adam Sherlock. Director of Life Sciences, CSC, which provides technology-enabled ­business solutions and services. For more ­information, visit csc.com.

Michael Sherman. Chief Financial Officer, Endocyte, a biopharmaceutical company ­developing targeted therapies for the ­treatment of cancer and other serious ­diseases. For more information, visit ­endocyte.com.

Jay Siegel, M.D. Chief Biotechnology ­Officer, and Head, Global Regulatory Affairs, Janssen Research & Development LLC,
part of the Janssen Pharmaceutical ­Companies of Johnson & Johnson,
which is dedicated to ­addressing and solving the most important unmet medical needs, in oncology, ­immunology, neuroscience, ­infectious disease, and cardiovascular, and metabolic diseases. For more information, visit janssenrnd.com.

Neeraj Singhal. VP, Product Management and Innovation, Cegedim Relationship ­Management, a provider of customer ­relationship management solutions. For more ­information, visit cegedim.com or email neeraj.singhal@cegedim.com.

Jon Smith. Director, Industry Development, Revitas, which delivers integrated solutions for contracts, pricing, and compliance. For more ­information, visit visit revitasinc.com or
blog.revitasinc.com.

Jeff Spanbauer. Chief Operating Officer, Principle, Healthcare Regional Marketing, a strategic healthcare marketing and ­deployment organization. For more ­information, hrmexperts.com.

Nagaraja Srivatsan. Senior VP and Head of Life Sciences, North America, Cognizant, a provider of consulting, analytics, information technology, and business process outsourcing services. For more information, visit cognizant.com.

Curt Staab. Executive Director, Sales ­Advisory Practice, TGaS Advisors, a division of KnowledgePoint360, is a provider of  ­benchmark and advisory services for pharmaceutical ­companies that enable them to evaluate their commercial operations against a confidential ­industry ­peer-set. For more information,
visit tgas.com.

Chuck Stevens. VP and General Manager, Commercialization Strategy, Parexel, a global bio/pharmaceutical services organization that helps clients expedite time-to-market through its development and launch services. For more information, visit parexel.com.

Anne Stroup. Managing Director, True Health + Wellness, a digital agency dedicated to both the broad market and the individual. For more information, visit truehw.com or email anne_stroup@truehw.com.

Prasad Subramani. Director, Analytics Practice, Cognizant, a provider of ­information technology, consulting, and ­business process outsourcing services. For more information, visit cognizant.com.

Debbie Thomas. Global VP, Regulatory ­Affairs, West Pharmaceutical Services, a provider of regulatory assistance to help ­improve the safe delivery of pharmaceutical, healthcare, and personal care products. For more information, visit westpharma.com.

Christopher Tobias, Ph.D. Executive VP, Chief Scientific Officer, Director of Business Development, Dudnyk, an independently owned, full-service branding, medical ­marketing, and advertising agency. For more information, visit dudnyk.com.

Al Topin. President, Topin & Associates, a full-service independent healthcare ­advertising agency. For more information, visit topin.com or email atopin@topin.com.

Michelle Vitko. Senior Research Analyst, Cutting Edge Information, a provider of ­management analysis reports, customized ­research and consulting. For more information, visit cuttingedgeinfo.com.

Matt Wallach. Chief Strategy Office and Co-Founder, Veeva Systems, a provider of cloud-based business solutions for the global life-sciences industry. For more information, visit veevasystems.com.

Anna Walz. CEO, Medisys Health ­Communications, which supports ­pharmaceutical, biopharmaceutical, and ­medical device partners with data-driven strategies for use across the professional ­communications spectrum. For more ­information, visit medisyshealth.com.

Scott Weintraub. Chief Marketing Officer, Healthcare Regional Marketing, a healthcare marketing and deployment ­organization. For more information, visit hrmexperts.com.

Karen Weiss, Ph.D. VP, Immunology Global Regulatory Affairs, at Janssen ­Research & Development LLC, part of the Janssen ­Pharmaceutical Companies of ­Johnson & ­Johnson, which is dedicated to ­addressing and solving the most important unmet medical needs, in oncology, ­immunology, neuroscience, infectious disease, and cardiovascular, and metabolic diseases. For more information, visit janssenrnd.com.

Wendy White. Founder and President, Siren Interactive, a digital relationship marketing agency focusing on rare disorder therapies. For more information, visit sireninteractive.com or follow on Twitter @sirenwendy.

Renée Wills. President, ICC Lowe, Trio, one of the healthcare arms of nine wholly owned ICC Lowe & Partner agencies. For more ­information, visit trio.icclowe.com.

Shaf Yousaf. Chief Marketing Officer, Sigma-Aldrich, which produces and sells a broad range of biochemicals, organic, and ­inorganic chemicals and related products. For more information, visit sigmaaldrich.com.

Todd Zander. VP, Product Management, ­Application Design and Innovation, WebMd,  an industry source for health and medical news and information. For more information, visit webmd.com.

David Zaritsky. President, Roska ­Healthcare Advertising, which executes ­professional and/or consumer advertising for a broad base of clients. For more information, visit roskahealthcare.com or email
dzaritsky@roskahealthcare.com.

FEEDBACK